Why Are We Still Using Hydrochlorothiazide

作者: Clive Rosendorff

DOI: 10.1111/J.1751-7176.2011.00566.X

关键词:

摘要:

参考文章(22)
George Davey Smith, Yiscah Bracha, Kenneth H. Svendsen, James D. Neaton, Steven M. Haffner, Lewis H. Kuller, , Incidence of Type 2 Diabetes in the Randomized Multiple Risk Factor Intervention Trial Annals of Internal Medicine. ,vol. 142, pp. 313- 322 ,(2005) , 10.7326/0003-4819-142-5-200503010-00006
Barry L. Carter, Michael E. Ernst, Jerome D. Cohen, Hydrochlorothiazide Versus Chlorthalidone: Evidence Supporting Their Interchangeability Hypertension. ,vol. 43, pp. 4- 9 ,(2004) , 10.1161/01.HYP.0000103632.19915.0E
Theodore W. Kurtz, Chlorthalidone: Don’t Call It “Thiazide-Like” Anymore Hypertension. ,vol. 56, pp. 335- 337 ,(2010) , 10.1161/HYPERTENSIONAHA.110.156166
Ryan Woodman, Christina Brown, Warren Lockette, Chlorthalidone Decreases Platelet Aggregation and Vascular Permeability and Promotes Angiogenesis Hypertension. ,vol. 56, pp. 463- 470 ,(2010) , 10.1161/HYPERTENSIONAHA.110.154476
Michael H. Alderman, Hillel Cohen, Shantha Madhavan, Diabetes and Cardiovascular Events in Hypertensive Patients Hypertension. ,vol. 33, pp. 1130- 1134 ,(1999) , 10.1161/01.HYP.33.5.1130
Kenneth Jamerson, Michael A Weber, George L Bakris, Björn Dahlöf, Bertram Pitt, Victor Shi, Allen Hester, Jitendra Gupte, Marjorie Gatlin, Eric J Velazquez, None, Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients The New England Journal of Medicine. ,vol. 359, pp. 2417- 2428 ,(2008) , 10.1056/NEJMOA0806182
John M. Flack, Domenic A. Sica, Shawna Nesbitt, Chlorthalidone Versus Hydrochlorothiazide as the Preferred Diuretic Is There a Verdict Yet Hypertension. ,vol. 57, pp. 665- 666 ,(2011) , 10.1161/HYPERTENSIONAHA.110.164566
Franz H. Messerli, Sripal Bangalore, Stevo Julius, Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension Circulation. ,vol. 117, pp. 2706- 2715 ,(2008) , 10.1161/CIRCULATIONAHA.107.695007
Tonje A. Aksnes, Sverre E. Kjeldsen, Morten Rostrup, Per Omvik, Tsushung A. Hua, Stevo Julius, Impact of New-Onset Diabetes Mellitus on Cardiac Outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Population Hypertension. ,vol. 50, pp. 467- 473 ,(2007) , 10.1161/HYPERTENSIONAHA.106.085654
Michael E. Ernst, Barry L. Carter, Chris J. Goerdt, Jennifer J.G. Steffensmeier, Beth Bryles Phillips, M. Bridget Zimmerman, George R. Bergus, Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure Hypertension. ,vol. 47, pp. 352- 358 ,(2006) , 10.1161/01.HYP.0000203309.07140.D3